Evaluating the validity of animal models for research into therapies for immune-based disorders

Bert A 't Hart, Sandra Amor, Margreet Jonker

Research output: Contribution to journalReview articleAcademicpeer-review


The last few decades of the 20th century have shown an intensified search for safer and more effective medications against chronic diseases that burden ageing societies of the western world. The impressive development of biotechnological production techniques has greatly facilitated the pharmaceutical development of relatively non-toxic biological molecules. However, despite the huge investments, only a few effective therapies for immune-based diseases have reached the clinic. In this article we use examples from monoclonal antibody trials to discuss the validity and predictive strength of the animal models currently used for the development of effective therapies.

Original languageEnglish
Pages (from-to)517-24
Number of pages8
JournalDrug Discovery Today
Issue number12
Publication statusPublished - 15 Jun 2004

Cite this